Sanofi ADR (NASDAQ:SNY) is a global biopharmaceutical company focused on human health. It researches, develops, and markets therapeutic solutions for a wide range of diseases, spanning from rare diseases and multiple sclerosis to oncology and immunology. With a strong presence in diabetes and cardiovascular treatments, Sanofi is also expanding its portfolio into hemophilia and other areas of significant unmet medical need. The company's projects aim to improve patient outcomes and quality of life across the globe through innovative medicines and vaccines. Objectives include driving sustainable growth, pioneering in areas of high medical need, and ensuring access to healthcare for patients worldwide. Sanofi is dedicated to making a difference in the lives of millions, leveraging research and development to bring transformative therapies from the lab to the people who need them most.